Savara Inc. (SVRA)
NASDAQ: SVRA · Real-Time Price · USD
5.45
-0.04 (-0.73%)
Aug 28, 2026, 9:55 AM EDT - Market open
Savara Employees
Savara had 70 employees as of December 31, 2025. The number of employees increased by 11 or 18.64% compared to the previous year.
Employees
70
Change (1Y)
11
Growth (1Y)
18.64%
Revenue / Employee
n/a
Profits / Employee
-$1,990,129
Market Cap
1.39B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Replimune Group | 465 |
| MeiraGTx Holdings | 393 |
| Alpha Tau Medical | 121 |
| ORIC Pharmaceuticals | 111 |
| Cullinan Therapeutics | 109 |
| Vor Biopharma | 76 |
| Alto Neuroscience | 68 |
| Seaport Therapeutics | 58 |
SVRA News
- 3 days ago - Savara announces presentations of Results from Phase 3 trial of Molgramostim - TheFly
- 3 days ago - Savara Announces Encore Presentations of Results from the Phase 3 Clinical Trial of Molgramostim Inhalation Solution (Molgramostim) in Autoimmune Pulmonary Alveolar Proteinosis (APAP) at the European Respiratory Society (ERS) Congress 2026 - Business Wire
- 7 days ago - Savara Announces New Employment Inducement Grant - Business Wire
- 16 days ago - Savara reports Q2 EPS (16c), consensus (15c) - TheFly
- 16 days ago - Savara Reports Second Quarter 2026 Financial Results and Provides Business Update - Business Wire
- 17 days ago - Savara Quarterly report: Q2 2026 - Filings
- 17 days ago - Savara Earnings release: Q2 2026 - Filings
- 17 days ago - Savara Slides: Corporate presentation - Filings